Huntingtin contains a highly conserved nuclear export signal

Human Molecular Genetics

Volumn 12, Issue 12, 2003, Pages 1393-1403

  Xia, Jianrun ^a   Lee, Denise H ^a   Taylor, Jillian ^a   Vandelft, Mark ^a   Truant, Ray ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; DNA FRAGMENT; HUNTINGTIN; LEPTOMYCIN B; MUTANT PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; POLYGLUTAMINE; REPETITIVE DNA;

AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN CELL; CARBOXY TERMINAL SEQUENCE; CELL CLONING; CELL COMPARTMENTALIZATION; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; DEGENERATIVE DISEASE; EXON; GENE IDENTIFICATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MICROSCOPY; MUTAGENESIS; NUCLEAR LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SPECIES DIVERSITY; TRINUCLEOTIDE REPEAT; VIDEORECORDING; WILD TYPE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; CELL SURVIVAL; CONSERVED SEQUENCE; CYTOPLASM; HELA CELLS; HUMANS; HUNTINGTON DISEASE; MICROSCOPY, VIDEO; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN TRANSPORT; SEQUENCE DELETION; TRINUCLEOTIDE REPEAT EXPANSION;

NES;

EID: 0037701612     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Cummings, C.J. and Zoghbi, H.Y. (2000) Fourteen and counting: unraveling trinucleotide repeat diseases. Hum. Mol. Genet., 9, 909-916.
2. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the ED gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
3. Menalled, L.B., Sison, J.D., Wu, Y., Olivieri, M., Li, X.J., Li, H., Zeitlin, S. and Chesselet, M.Y. (2002) Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J. Neurosci., 22, 8266-8276.
4. Lin, C.H., Tallaksen-Greene, S., Chien, W.M., Cearley, J.A., Jackson, W.S., Crouse, A.B., Ren, S., Li, X.J., Albin, R.L. and Detloff, P.J. (2001) Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet., 10, 137-144.
5. Wheeler, V.C., Gutekunst, C.A., Vrbanac, V., Lebel, L.A., Schilling, G., Hersch, S., Friedlander, R.M., Gusella, J.F., Vonsattel, J.P., Borchelt, D.R. et al. (2002) Early phenotypes tat presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum. Mol. Genet., 11, 633-640.
6. Shelbourne, P.F., Killeen, N., Hevner, R.F., Jobnston, H.M., Tecott, L., Lewandoski, M., Ennis, M., Ramirez, L., Li, Z., Iannicola, C. et al. (1999) A Huntington's disease CAG expansion at the marine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum. Mol. Genet., 8, 763-774.
7. Hodgson, J.G., Agopyan, N., Gutekunst, C.A., Leavilt, B.R., LePiane, F., Singaraja, R., Smith, D.J., Bissada, N., McCutcheon, K., Nasir, J. et al. (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron, 23, 181-192.
8. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P. and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science, 277, 1990-1993.
9. Gutekunst, C.A., Levey, A.I., Heilman, C.J., Whaley, W.L., Yi, H., Nash, N.R., Rees, H.D., Madden, J.J. and Hersch, S.M. (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc. Natl Acad. Sci. USA, 92, 8710-8714.
10. Cooper, J.K., Schilling, G., Peters, M.F., Herring, W.J., Sharp, A.H., Kaminsky, Z., Masone, J., Khan, F.A., Delanoy, M., Borchelt, D.R. et al. (1998) Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet., 7, 783-790.
11. Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntinglin acts in the nucleus to induce apoptosis but death does not correlate with die formation of intranuclear inclusions. Cell, 95, 55-66.
12. Kuemmerle, S., Gutekunst, C.A., Klein, A.M., Li, X.J., Li, S.H., Beal, M.F., Hersch, S.M. and Ferrante, R.J. (1999) Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol., 46, 842-849.
13. De Rooij, K.E., Dorsman, J.C., Smoor, M.A., Den Dunnen, J.T. and Van Ommen, G.J. (1996) Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet., 5, 1093-1099.
14. Hilditch-Maguire, P., Trettel, F., Passani, L.A., Auerbach, A., Persichetti, F. and MacDonald, M.E. (2000) Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum. Mol. Genet., 9, 2789-2797.
15. Tao, T. and Tartakoff, A.M. (2001) Nuclear relocation of normal huntingtin. Traffic, 2, 385-394.
16. Kegel, K.B., Meloni, A.R., Yi, Y., Kim, Y.J., Doyle, E., Cuiffo, B.G., Sapp, E., Wang, Y., Qin, Z.H., Chen, J.D. et al. (2001) Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J. Biol. Chem., 277, 7466-7476.
17. Ross, CA. (1997) intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron, 19, 1147-1150.
18. Sieradzan, K.A., Mechan, A.O., Jones, L., Wanker, E.E., Nukina, N. and Mann, D.M. (1999) Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp. Neurol., 156, 92-99.
19. Peters, M.F., Nucifora, F.C. Jr, Kushi, J., Seaman, H.C., Cooper, J.K., Herring, W.J., Dawson, V.L., Dawson, T.M. and Ross, C.A. (1999) Nuclear targeting of mutant Huntingtin increases toxicity Mol. Cell. Neurosci., 14, 121-128.
20. Gutekunst, C.A., Li, S.H., Yi, H., Mulroy, J.S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R.J., Hersch, S.M. and Li, X.J. (1999) Nuclear and neuropil a gregates in Huntington's disease: relationship to neuropathology. J. Neurosci., 19, 2522-2534.
21. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y. and Orr, H.T. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell, 95, 41-53.
22. Hackam, A.S., Singaraja, R., Wellington, C.L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M. and Hayden, M.R. (1998) The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell. Biol., 141, 1097-1105.
23. Bessert, D.A., Gutridge, K.L., Dunbar, J.C. and Carlock, L.R. (1995) The identification of a functional nuclear localization signal in the Huntington disease protein. Brain Res. Mol. Brain Res., 33, 165-173.
24. Preisinger, F., Jordan, B.M., Kazantsev, A. and Housman, D. (1999) Evidence for a recruitment and sequestration mechanism in Huntington's disease. Phil. Trans. R. Soc. Lond B. Biol. Sci., 354, 1029-1034.
25. Trettel, F., Rigamonti, D., Hilditch-Maguire, P., Wheeler, V.C., Sharp, A.H., Persichetti, F., Cattaneo, F. and MacDonald, M.E. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells, Hum. Mol. Genet., 9, 2799-2809.
26. Sorg, G. and Stamminger, T. (1999) Mapping of nuclear localization signals by simultaneous fusion to green fluorescent protein and to beta-galactosidase. Biotechniques, 26, 858-862.
27. Truant, R., Fridell, R.A., Benson, R.E., Bogerd, H. and Cullen, B.R. (1998) Identification and functional characterization of a novel nuclear localization signal present in the yeast Nab2 poly(A) + RNA binding protein. Mol. Cell. Biol., 18, 1449-1458.
28. Truant, R., Kang, Y. and Cullen, B.R. (1999) The human tap nuclear RNA export factor contains a novel transportin-dependent nuclear localization signal that lacks nuclear export signal function. J. Biol. Chem., 274, 32167-32171.
29. Bogerd, H.P., Fridell, R.A., Benson, RE., Hua, J. and Cullen, B.R. (1996) Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol. Cell. Biol., 16, 4207-4214.
30. Fahrenkrog, B., Stoffler, D. and Aebi, U. (2001) Nuclear pore complex architecture and functional dynamics. Curr. Top. Microbiol. Immunol., 259, 95-117.
31. Truant, R. and Cullen, B.R. (1999) The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol. Cell. Biol., 19, 1210-1217.
32. Pollard, V.W., Michael, W.M., Nakielny, S., Siomi, M.C., Wang, F. and Dreyfuss, G. (1996) A novel receptor-mediated nuclear protein import pathway. Cell, 86, 985-994.
33. Barer, M.R. (1991) New possibilities for bacterial cytochemistry: light microscopical demonstration ofbeta-galactosidase in unfixed immobilized bacteria. Histochem. J., 23, 529-533.
34. Faber, P.W., Barnes, G.T., Srinidhi, J., Chen, I, Gusella, J.F. and MacDonald, M.E. (1998) Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet., 7, 1463-1474.
35. Dupont, S., Sharova, N., DeHoratius, C., Virbasius, C.M., Zhu, K., Bukrinskaya, A.G., Stevenson, M. and Green, MY. (1999) A novel nuclear, export activity in HIV-1 matrix protein required for viral replication. Nature, 402, 681-685.
36. Fischer, U., Huber, J., Boelens, W.C., Mattaj, I.W. and Luhrmann, R. (1995) The HIV-I Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell, 82, 475-483.
37. Malim, M.H., Freimuth, W.W., Liu, J., Boyle, T.J., Lyerly, H.K., Cullen, B.R. and Nabel, G.J. (1992) Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med., 176, 1197-1201.
38. Yoneda, Y. (1997) How proteins are transported from cytoplasm to the nucleus. J. Biochem. (Tokyo), 121, 811-847.
39. Wolff, B., Sanglier, J.J. and Wang, Y. (1997) LeptomycinB is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type I (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol., 4, 139-147.
40. Fornerod, M., Ohno, M., Yoshida, M. and Mattaj, J.W. (1997) CRMI is an export receptor for leucine-rich nuclear export signals. Cell, 90, 1051-1060.
41. Kudo, N., Wolff, B., Sekimoto, T., Schreiner, E.P., Yoneda, Y., Yanagida, M., Horinouchi, S. and Yoshida, M. (1998) Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell. Res., 242, 540-547.
42. Adam, S.A., Sterne-Marr, R. and Gerace, L. (1992) Nuclear protein import using digitonin-permeabilized cells. Meth. Enzymol., 219, 97-110.
43. Tsuji, L., Takumi, T., Inamoto, N. and Yoneda, Y. (1997) Identification of novel homologues of mouse importin alpha, the alpha subunit of the nuclear pore-targeting complex, and their tissue-specific expression. FEBS Lett., 416, 30-34.
44. Gines, S., Seong, I.S., Fossale, E., Ivanova, F., Trettel, F., Gusella, J.F., Wheeler, V.C., Persichetti, F. and MacDonald, M.E. (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum. Mol. Genet., 12, 497-508.
45. Seipel, K., Georgiev, O., Gerber, H.P. and Schaffher, W. (1994) Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a 'portable enhancer domain'? Mol. Reprod Dev., 39, 215-225.
46. McCampbell, A. and Fischbeck, K.H. (2001) Polyglutamine and CBP: fatal attraction? Nat. Med., 7, 528-530.
47. Kalijo, P.J., Okamoto, K., O'Brien, S., Carrero, P., Makino, Y., Tanaka, H. and Poellinger, L. (1998) Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1 alpha. EMBO J., 17, 6573-6586.
48. Pemberton, L.F., Rosenblum, J.S. and Bobel, G. (1999) Nuclear import of the TATA-binding protein: mediation by the karyopherin Kapil14p and a possible mechanism for intranuclear targeting. J. Cell Biol., 145, 1407-1417.
49. Holbert, S., Denghien, I., Kiechle, T., Rosenblatt, A., Wellington, C., Hayden. M.R., Margolis, R.L., Ross, C.A., Dausset, J., Ferrante, R.J. et al. (2001) The Gln-Ala repeat transcriptional activator CA 150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc. Natl Acad. Sci. USA, 98, 1811-1816.
50. Huang, C.C., Faber, P.W., Persichetti, F., Mittal, V., Vonsattel, J.P., MacDonald, M.E. and Gusella, J.F. (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell Mol. Genet., 24, 217-233.
51. Passani, L.A., Bedford, M.T., Faber, P.W., McGinnis, K.M., Sharp, A.H., Gusella, J.F., Vonsattel, J.P. and MacDonald, M.E. (2000) Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis. Hum. Mol. Genet., 9, 2175-2182.
52. Persichetti, F., Trettel, F., Huang, C.C., Fraefel, C., Timmers, H.T., Gusella, J.F. and MacDonald, M.E. (1999) Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutainine segment. Neurobiol. Dis., 6, 364-375.
53. Andrade, M.A. and Bork, P. (1995) HEAT repeats in the Huntington's disease protein. Nat. Genet., 11, 115-116.
54. Suhr, S.T., Senut, M.C., Whitelegge, J.P., Faull, K.F., Cuizon, D.B. and Gage, F.H. (2001) Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J. Cell Biol., 153, 283-294.
55. Weis, K. (2003) Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell, 112, 441-451.
56. Hattula, K. and Peranen, J. (2000) FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr. Biol., 10, 1603-1606.
57. Hoffner, G., Kahiem, P. and Djian, P. (2002) Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. J. Cell Sci., 115, 941-948.
58. Gusella, J.F. and MacDonald, M.E. (1998) Huntingtin: a single bait hooks many species. Curr. Opin. Neurobiol., 8, 425-430.
59. Huang, T.T. and Miyamoto, S. (2001) Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha. Mol. Cell. Biol., 21, 4737-4747.
60. Johnson, C., Van Antwerp, D. and Hope, T.J. (1999) An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. EMBO J., 18, 6682-6693.
61. Rega, S., Stiewe, T., Chang, D.I., Pollmeier, B., Esche, H., Bardenheuer, W., Marquitan, G. and Putzer, B.M. (2001) Identification of the full-length huntingtin-interacting protein p23IHBP/HYPB as a DNA-binding factor. Mol. Cell. Neurosci., 18, 68-79.
62. Neufeld, K.L., Nix, D.A., Bogerd, H., Kang, Y., Beckerle, M.C., Cullen, B.R. and White, R.L. (2000) Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc. Natl Acad. Sci. USA, 97, 12085-12090.
63. Hendeson, B.R. (2000) Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol., 2, 653-660.
64. Wanker, E.E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, I and Lehrach, H. (1997) HIP-I: a huntingtjn interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet., 6, 487-495.
65. Pederson, T. (1999) Movement and localization of RNA in the cell nucleus. FASEB J., 13 (Suppl. 2), S238-242.
66. Bardoni, B., Schenck, A. and Mandel, J.L. (2001) The Fragile X mental retardation protein. Brain Res. Bull., 56, 375-382.
67. Brown, V., Jin, P., Ceman, S., Darnell, J.C., O'Donnell, W.T., Tenenbaum, S.A., Jin, X., Feng, Y., Wilkinson, K.D., Keene, J.D. et al. (2001) Microarray Identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in Fragile X syndrome. Cell, 107, 477-487.
68. Fridell, R.A., Benson, R.E., Hua, J., Bogerd, H.P. and Cullen, W.R. (1996) A nuclear role for the Fragile X mental retardation protein. EMBO J., 15, 5408-5414.
69. Mende-Mueller, L.M., Toneff, T., Hwang, S.R., Chesselet, M.F. and Hook, V.Y. (2001) Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal hU fragments in Huntington's disease striatum. J. Neurosci., 21, 1830-1837.
70. Wellington, C.L., Ellerby, L.M., Hackam, A.S., Margolis, R.L., Trifiro, M.A., Singaraja, R., McCutcheon, K., Salvesen, G.S., Propp, S.S., Bromm, M. et al. (1998) Caspase cleavage of gene products associated wit triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem., 273, 9158-9167.
71. Li, H., Li, S.H. Johnston, H., Shelbourne, P.F. and Li, X.J. (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet., 25, 385-389.
72. Kim, S., Nollen, E.A., Kitagawa, K., Bindokas, V.P. and Morimoto, R.I. (2002) Polyglutamine protein aggregates are dynamic. Nat. Cell Biol., 4, 826-831.
73. Chai, Y., Shao, J., Miller, V.M., Williams, A. and Paulson, H.L. (2002) Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc. Natl Acad. Sci. USA, 99, 9310-9315.